BioSpace News Archive

Onconova Therapeutics, Inc. (NASDAQ: ONTX), (“Onconova”), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer, today announced that the Company will be participating virtually in the H.C. Wainwright 24th Annual Global Investment Conference.

Avails Medical, a pioneer in rapid, automated, and fully electrical antibiotic susceptibility testing (eAST™) announced today the transition to the next phase of its CARB-X grant.

9 Meters Biopharma, Inc., a clinical-stage company pioneering novel treatments for people with rare or debilitating digestive diseases, announced that the company will participate at the 44th European Society for Clinical Nutrition and Metabolism Congress taking place September 3-6, 2022, in Vienna.

Avinger, Inc. announced the presentation of interim data from the IMAGE-BTK clinical study for Pantheris SV at the annual AMP conference in August.

bioAffinity Technologies, Inc. announced that its initial public offering of 1,282,600 units of securities has been priced at $6.125 per unit.

Stryker has launched the Gamma4 System, strengthening the product’s 30-year legacy of continuous innovation and clinical history.

Celsion Corporation (NASDAQ: CLSN), a clinical-stage company focused on DNA-based immunotherapy and next-generation vaccines, today provided an update on the progress made in the development of a DNA-based vaccine using its PLACCINE platform technology.

AlgoTx, a biotechnology company dedicated to developing treatments for complex pain, announced today the initiation of its Phase 2 global clinical trial in Chemotherapy-Induced Peripheral Neuropathy in adult patients.

Revelle Aesthetics, Inc. (Revelle) – a VC-backed Silicon Valley MedTech company – achieves an extended FDA clearance for its precision cellulite release device, Avéli™.

Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) (NASDAQ: IINNW) (the “Company” or “Inspira Technologies”), a groundbreaking respiratory support technology company, today announced that Joe Hayon, President and Co-Founder of Inspira Technologies, will present at the H.C. Wainwright 24th Annual Global Investor Conference on Monday, September 12, 2022.